Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.

Authors

Lawrence DuBuske, George Washington University
Paul Newbold
Yanping Wu
Frank Trudo

Document Type

Journal Article

Publication Date

9-4-2018

Journal

Allergy and asthma proceedings : the official journal of regional and state allergy societies

Volume

39

Issue

5

Inclusive Pages

345-349

DOI

10.2500/aap.2018.39.4162

Keywords

Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Disease Progression; Drug Therapy, Combination; Eosinophils; Hospitalization; Humans; Seasons; Severity of Illness Index; Treatment Outcome

APA Citation

DuBuske, L., Newbold, P., Wu, Y., & Trudo, F. (2018). Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.. Allergy and asthma proceedings : the official journal of regional and state allergy societies, 39 (5). http://dx.doi.org/10.2500/aap.2018.39.4162

Peer Reviewed

1